322 related articles for article (PubMed ID: 26202882)
61. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.
Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B
Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505
[TBL] [Abstract][Full Text] [Related]
62. Caffeic Acid Phenethyl Ester Induces
Chiang KC; Yang SW; Chang KP; Feng TH; Chang KS; Tsui KH; Shin YS; Chen CC; Chao M; Juang HH
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738439
[TBL] [Abstract][Full Text] [Related]
63. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
[TBL] [Abstract][Full Text] [Related]
64. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1.
Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2644-2663. PubMed ID: 29679718
[TBL] [Abstract][Full Text] [Related]
65. Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.
Li Z; Li W; Xie J; Wang Y; Tang A; Li X; Ye J; Gui Y; Cai Z
Cell Biol Int; 2011 Jul; 35(7):671-6. PubMed ID: 21314642
[TBL] [Abstract][Full Text] [Related]
66. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
67. The metastasis suppressor NDRG1 modulates the phosphorylation and nuclear translocation of β-catenin through mechanisms involving FRAT1 and PAK4.
Jin R; Liu W; Menezes S; Yue F; Zheng M; Kovacevic Z; Richardson DR
J Cell Sci; 2014 Jul; 127(Pt 14):3116-30. PubMed ID: 24829151
[TBL] [Abstract][Full Text] [Related]
68. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
69. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
70. Expression and biological function of N-myc down-regulated gene 1 in human cervical cancer.
Wang J; Cai J; Li Z; Hu S; Yu L; Xiao L; Wang Z
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):771-6. PubMed ID: 21181370
[TBL] [Abstract][Full Text] [Related]
71. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
72. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
73. HIC1 modulates prostate cancer progression by epigenetic modification.
Zheng J; Wang J; Sun X; Hao M; Ding T; Xiong D; Wang X; Zhu Y; Xiao G; Cheng G; Zhao M; Zhang J; Wang J
Clin Cancer Res; 2013 Mar; 19(6):1400-10. PubMed ID: 23340301
[TBL] [Abstract][Full Text] [Related]
74. Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors.
Pulukuri SM; Patibandla S; Patel J; Estes N; Rao JS
Oncogene; 2007 Aug; 26(36):5229-37. PubMed ID: 17325663
[TBL] [Abstract][Full Text] [Related]
75. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NFkappaB complex in human prostate cancer.
Liu W; Iiizumi-Gairani M; Okuda H; Kobayashi A; Watabe M; Pai SK; Pandey PR; Xing F; Fukuda K; Modur V; Hirota S; Suzuki K; Chiba T; Endo M; Sugai T; Watabe K
J Biol Chem; 2011 May; 286(21):18949-59. PubMed ID: 21454613
[TBL] [Abstract][Full Text] [Related]
76. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
[TBL] [Abstract][Full Text] [Related]
77. ETS1 regulates NDRG1 to promote the proliferation, migration, and invasion of OSCC.
Sheng X; Li X; Qian Y; Wang S; Xiao C
Oral Dis; 2024 Apr; 30(3):977-990. PubMed ID: 36718855
[TBL] [Abstract][Full Text] [Related]
78. N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells.
Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
[TBL] [Abstract][Full Text] [Related]
79. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
80. Targeting the metastasis suppressor, NDRG1, using novel iron chelators: regulation of stress fiber-mediated tumor cell migration via modulation of the ROCK1/pMLC2 signaling pathway.
Sun J; Zhang D; Zheng Y; Zhao Q; Zheng M; Kovacevic Z; Richardson DR
Mol Pharmacol; 2013 Feb; 83(2):454-69. PubMed ID: 23188716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
